Byrd lands with the Sox, again.
The Red Sox have signed free-agent righthander Paul Byrd to a minor league contract. Byrd, 38, is expected to pitch in the minor leagues and be ready to join the major league staff around Sept. 1, according to FoxSports.com’s Ken Rosenthal. He has yet to pitch this season.
On Aug. 12, 2008, the Sox acquired Byrd from the Cleveland Indians after Byrd had cleared waivers. Byrd went 4-2 with a 4.78 ERA in 49 innings for Boston during the remainder of the regular season.
Byrd last pitched for the Sox during Game 3 of the ALCS against the Rays at Fenway Park. He went 3 1/3 innings in relief of Jon Lester, giving up four earned runs on five hits, including home runs to Carlos Pena and Rocco Baldelli, in the 9-1 postseason loss.
Byrd went 15-11 for Philadelphia in 1999 in the third of Terry Francona’s four seasons as manager there and made the NL All-Star team
Over a 13-year span in the major leagues, the soft-tossing Byrd has pitched for the Mets, Braves, Phillies, Royals, Angels, Indians, and Red Sox. He has 108 wins to go along with 93 losses and a 4.38 career ERA. Byrd had retired after the 2008 season.
During the fall of 2007, the San Francisco Chronicle reported before Game 7 of that season’s ALCS that Byrd, then a member of the Indians, had purchased $25,000 worth of human growth hormone (HGH) and syringes from an anti-aging clinic between August 2002 and August 2005. Byrd said before Game 7 that he had used it for a medical condition but that he never injected the banned drug without a doctor’s prescription. Like all players named in the Mitchell Report, Byrd was later granted amnesty for his involvement with HGH.